Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered MicroRNA...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Altered microRNA (miRNA) expression is linked to various cancers.
• Tumor tissues comprise cancer cells and a heterogeneous microenvironment.
• Understanding miRNA localization is crucial for cancer research.

Purpose of the Study:

• To develop a sensitive fluorescence-based in situ hybridization (ISH) method for visualizing miRNA accumulation in individual cells.
• To enable simultaneous detection of miRNAs and protein markers using combined ISH/immunohistochemistry (IHC) assays.
• To clarify the clinical significance of altered miRNA expression in solid tumors.

Main Methods:

• A combined ISH/IHC assay was developed for formalin-fixed, paraffin-embedded tissue specimens.
• The assay was used to study cancer-associated miRNAs (miR-34a, miR-126, miR-21, miR-155) in breast, colorectal, lung, pancreas, and prostate carcinomas.
• This method allows for colocalization and functional studies of miRNAs and proteins.

Main Results:

• Distinct cellular sources of altered miRNA expression were identified across different cancer types.
• miR-21 and miR-34a were primarily found in cancer cells.
• miR-126 and miR-155 were predominantly localized in endothelial and immune cells, respectively.
• These findings suggest miRNAs influence cancer through direct effects on cancer cells or modulation of the tumor microenvironment.

Conclusions:

• A rapid, sensitive, multicolor ISH/IHC assay was developed.
• This assay serves as a valuable tool for investigating the etiologic relevance of altered miRNA expression in cancer.
• The study provides insights into the heterogeneous roles of miRNAs in carcinogenesis.